{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T08:40:01Z","timestamp":1794559201500,"version":"4.9.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T00:00:00Z","timestamp":1654560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T00:00:00Z","timestamp":1654560000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100010564","name":"Academic Medical Organization of Southwestern Ontario","doi-asserted-by":"publisher","award":["INN19-006"],"award-info":[{"award-number":["INN19-006"]}],"id":[{"id":"10.13039\/100010564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008958","name":"lawson health research institute","doi-asserted-by":"publisher","award":["Fall 2018 Internal Research Fund (IRF)"],"award-info":[{"award-number":["Fall 2018 Internal Research Fund (IRF)"]}],"id":[{"id":"10.13039\/100008958","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Idiopathic pulmonary fibrosis (IPF) is associated with increased expression of cyclin-dependent kinase inhibitors such as p16 and p21, and subsequent induction of cell cycle arrest, cellular senescence, and pro-fibrotic gene expression. We sought to link p16-expression with a diagnosis of IPF or other fibrotic interstitial lung diseases (ILDs), radiographic pattern, senescent foci-specific gene expression, antifibrotic therapy response, and lung transplant (LTx)-free survival.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Eighty-six cases of fibrosing ILD were identified with surgical lung biopsy. Immunohistochemistry for p16 was performed on sections with the most active fibrosis. p16-positive foci (loose collection of p16-positive fibroblasts with overlying p16-positive epithelium) were identified on digital slides and quantified. Cases were scored as p16-low (\u2264\u20092.1 foci per 100\u00a0mm<jats:sup>2<\/jats:sup>) or p16-high (&gt;\u20092.1 foci per 100\u00a0mm<jats:sup>2<\/jats:sup>). Twenty-four areas including senescent foci, fibrotic and normal areas were characterized using in situ RNA expression analysis with digital spatial profiling (DSP) in selected cases.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The presence of p16-positive foci was specific for the diagnosis of IPF, where 50% of cases expressed any level of p16 and 26% were p16-high. There was no relationship between radiographic pattern and p16 expression. However, there was increased expression of cyclin-dependent kinase inhibitors, collagens and matrix remodeling genes within p16-positive foci, and cases with high p16 expression had shorter LTx-free survival. On the other hand, antifibrotic therapy was significantly protective. DSP demonstrated that fibroblastic foci exhibit transcriptional features clearly distinct from that of normal-looking and even fibrotic areas.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>We demonstrated the potential clinical applicability of a standardized quantification of p16-positive fibroblastic foci. This method identifies an IPF phenotype associated with foci-specific upregulation of senescence-associated and matrix remodeling gene expression. While these patients have reduced LTx-free survival, good response to antifibrotic therapies was observed in those who were treated.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12931-022-02067-w","type":"journal-article","created":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T16:09:48Z","timestamp":1654618188000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Digital quantification of p16-positive foci in fibrotic interstitial lung disease is associated with a phenotype of idiopathic pulmonary fibrosis with reduced survival"],"prefix":"10.1186","volume":"23","author":[{"given":"Jonathan","family":"Keow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Cecchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathashi","family":"Jayawardena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Zompatori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariamma G.","family":"Joseph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2159-7083","authenticated-orcid":false,"given":"Marco","family":"Mura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,7]]},"reference":[{"key":"2067_CR1","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/S2213-2600(17)30433-2","volume":"6","author":"DA Lynch","year":"2018","unstructured":"Lynch DA, Sverzellati N, Travis WD, et al. Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White Paper. Lancet Respir Med. 2018;6:138\u201353. https:\/\/doi.org\/10.1016\/S2213-2600(17)30433-2.","journal-title":"Lancet Respir Med"},{"key":"2067_CR2","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.chest.2018.12.011","volume":"155","author":"A Adegunsoye","year":"2019","unstructured":"Adegunsoye A, Vij R, Noth I. Integrating genomics into management of fibrotic interstitial lung disease. Chest. 2019;155:1026\u201340. https:\/\/doi.org\/10.1016\/j.chest.2018.12.011.","journal-title":"Chest"},{"key":"2067_CR3","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1097\/MCP.0b013e32832ea4b3","volume":"15","author":"SK Frankel","year":"2009","unstructured":"Frankel SK, Schwarz MI. Update in idiopathic pulmonary fibrosis. Curr Opin Pulm Med. 2009;15:463\u20139. https:\/\/doi.org\/10.1097\/MCP.0b013e32832ea4b3.","journal-title":"Curr Opin Pulm Med"},{"key":"2067_CR4","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1164\/rccm.201006-0894CI","volume":"183","author":"B Ley","year":"2011","unstructured":"Ley B, Collard HR, King TE. Clinical course and prediction of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2011;183:431\u201340. https:\/\/doi.org\/10.1164\/rccm.201006-0894CI.","journal-title":"Am J Respir Crit Care Med"},{"key":"2067_CR5","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1183\/09031936.00106011","volume":"40","author":"M Mura","year":"2012","unstructured":"Mura M, Porretta MA, Bargagli E, et al. Predicting survival in newly diagnosed idiopathic pulmonary fibrosis: a 3-year prospective study. Eur Respir J. 2012;40:101\u20139. https:\/\/doi.org\/10.1183\/09031936.00106011.","journal-title":"Eur Respir J"},{"key":"2067_CR6","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1056\/nejmoa1402582","volume":"370","author":"TE King","year":"2014","unstructured":"King TE, Bradford WZ, Castro-Bernardini S, et al. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med. 2014;370:2083\u201392. https:\/\/doi.org\/10.1056\/nejmoa1402582.","journal-title":"N Engl J Med"},{"key":"2067_CR7","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1056\/nejmoa1402584","volume":"370","author":"L Richeldi","year":"2014","unstructured":"Richeldi L, du Bois RM, Raghu G, et al. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med. 2014;370:2071\u201382. https:\/\/doi.org\/10.1056\/nejmoa1402584.","journal-title":"N Engl J Med"},{"key":"2067_CR8","doi-asserted-by":"publisher","first-page":"767","DOI":"10.7326\/0003-4819-151-11-200912010-00004","volume":"151","author":"G Thabut","year":"2009","unstructured":"Thabut G. Survival after bilateral versus single-lung transplantation for idiopathic pulmonary fibrosis. Ann Intern Med. 2009;151:767\u201374. https:\/\/doi.org\/10.7326\/0003-4819-151-11-200912010-00004.","journal-title":"Ann Intern Med"},{"key":"2067_CR9","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1378\/chest.128.4.2375","volume":"128","author":"L Tiitto","year":"2005","unstructured":"Tiitto L, Heiskanen U, Bloigu R, et al. Thoracoscopic lung biopsy is a safe procedure in diagnosing usual interstitial pneumonia. Chest. 2005;128:2375\u201380. https:\/\/doi.org\/10.1378\/chest.128.4.2375.","journal-title":"Chest"},{"key":"2067_CR10","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1378\/chest.125.2.522","volume":"125","author":"H Monaghan","year":"2004","unstructured":"Monaghan H, Wells AU, Colby TV, et al. Prognostic implications of histologic patterns in multiple surgical lung biopsies from patients with idiopathic interstitial pneumonias. Chest. 2004;125:522\u20136. https:\/\/doi.org\/10.1378\/chest.125.2.522.","journal-title":"Chest"},{"key":"2067_CR11","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1136\/thoraxjnl-2019-213865","volume":"75","author":"J Jacob","year":"2020","unstructured":"Jacob J, Aksman L, Mogulkoc N, et al. Serial CT analysis in idiopathic pulmonary fibrosis: comparison of visual features that determine patient outcome. Thorax. 2020;75:648\u201354. https:\/\/doi.org\/10.1136\/thoraxjnl-2019-213865.","journal-title":"Thorax"},{"key":"2067_CR12","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1164\/rccm.200204-373OC","volume":"167","author":"KR Flaherty","year":"2003","unstructured":"Flaherty KR, Colby TV, Travis WD, et al. Fibroblastic foci in usual interstitial pneumonia: Idiopathic versus collagen vascular disease. Am J Respir Crit Care Med. 2003;167:1410\u20135. https:\/\/doi.org\/10.1164\/rccm.200204-373OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"2067_CR13","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.rmed.2008.01.012","volume":"102","author":"V Hanak","year":"2008","unstructured":"Hanak V, Ryu JH, de Carvalho E, et al. Profusion of fibroblast foci in patients with idiopathic pulmonary fibrosis does not predict outcome. Respir Med. 2008;102:852\u20136. https:\/\/doi.org\/10.1016\/j.rmed.2008.01.012.","journal-title":"Respir Med"},{"key":"2067_CR14","doi-asserted-by":"publisher","first-page":"eaba1983","DOI":"10.1126\/sciadv.aba1983","volume":"6","author":"TS Adams","year":"2020","unstructured":"Adams TS, Schupp JC, Poli S, et al. Single-cell RNA-seq reveals ectopic and aberrant lung-resident cell populations in idiopathic pulmonary fibrosis. Sci Adv. 2020;6:eaba1983. https:\/\/doi.org\/10.1126\/sciadv.aba1983.","journal-title":"Sci Adv"},{"key":"2067_CR15","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1164\/rccm.202004-1274OC","volume":"203","author":"C Yao","year":"2021","unstructured":"Yao C, Guan X, Carraro G, et al. Senescence of alveolar type 2 cells drives progressive pulmonary fibrosis. Am J Respir Crit Care Med. 2021;203:707\u201317. https:\/\/doi.org\/10.1164\/rccm.202004-1274OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"2067_CR16","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/his.14334","volume":"79","author":"JS Lee","year":"2021","unstructured":"Lee JS, La J, Aziz S, et al. Molecular markers of telomere dysfunction and senescence are common findings in the usual interstitial pneumonia pattern of lung fibrosis. Histopathology. 2021;79:67\u201376. https:\/\/doi.org\/10.1111\/his.14334.","journal-title":"Histopathology"},{"key":"2067_CR17","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1164\/rccm.201810-1975TR","volume":"200","author":"PJ Barnes","year":"2019","unstructured":"Barnes PJ, Baker J, Donnelly LE. Cellular senescence as a mechanism and target in chronic lung diseases. Am J Respir Crit Care Med. 2019;200:556\u201364. https:\/\/doi.org\/10.1164\/rccm.201810-1975TR.","journal-title":"Am J Respir Crit Care Med"},{"key":"2067_CR18","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s12931-018-0857-1","volume":"19","author":"MJ Cecchini","year":"2018","unstructured":"Cecchini MJ, Hosein K, Howlett CJ, et al. Comprehensive gene expression profiling identifies distinct and overlapping transcriptional profiles in non-specific interstitial pneumonia and idiopathic pulmonary fibrosis. Respir Res. 2018;19:153. https:\/\/doi.org\/10.1186\/s12931-018-0857-1.","journal-title":"Respir Res"},{"key":"2067_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14532","author":"MJ Schafer","year":"2017","unstructured":"Schafer MJ, White TA, Iijima K, et al. Cellular senescence mediates fibrotic pulmonary disease. Nat Commun. 2017. https:\/\/doi.org\/10.1038\/ncomms14532.","journal-title":"Nat Commun."},{"key":"2067_CR20","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1164\/rccm.200402-147OC","volume":"170","author":"KR Flaherty","year":"2004","unstructured":"Flaherty KR, King TE, Raghu G, et al. Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis? Am J Respir Crit Care Med. 2004;170:904\u201310. https:\/\/doi.org\/10.1164\/rccm.200402-147OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"2067_CR21","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1164\/ajrccm.152.3.7663792","volume":"152","author":"O Crapo","year":"1995","unstructured":"Crapo O, Hankinson JL, Irvin C, et al. Standardization of spirometry: 1994 update. Am J Respir Crit Care Med. 1995;152:1107\u201336. https:\/\/doi.org\/10.1164\/ajrccm.152.3.7663792.","journal-title":"Am J Respir Crit Care Med"},{"key":"2067_CR22","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1183\/09031936.05.00034805","volume":"26","author":"MR Miller","year":"2005","unstructured":"Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J. 2005;26:319\u201338. https:\/\/doi.org\/10.1183\/09031936.05.00034805.","journal-title":"Eur Respir J"},{"key":"2067_CR23","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1183\/09031936.05.00035005","volume":"26","author":"J Wanger","year":"2005","unstructured":"Wanger J, Clausen JL, Coates A, et al. Standardisation of the measurement of lung volumes. Eur Respir J. 2005;26:511\u201322. https:\/\/doi.org\/10.1183\/09031936.05.00035005.","journal-title":"Eur Respir J"},{"key":"2067_CR24","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00962-2016","author":"GS Zavorsky","year":"2017","unstructured":"Zavorsky GS, Hsia CCW, Hughes JMB, et al. Standardisation and application of the single-breath determination of nitric oxide uptake in the lung. Eur Respir J. 2017. https:\/\/doi.org\/10.1183\/13993003.00962-2016.","journal-title":"Eur Respir J"},{"key":"2067_CR25","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.1164\/rccm.201807-1255ST","volume":"198","author":"G Raghu","year":"2018","unstructured":"Raghu G, Remy-Jardin M, Myers JL, et al. Diagnosis of idiopathic pulmonary fibrosis an official ATS\/ERS\/JRS\/ALAT clinical practice guideline. Am J Respir Crit Care Med. 2018;198:e44-68. https:\/\/doi.org\/10.1164\/rccm.201807-1255ST.","journal-title":"Am J Respir Crit Care Med"},{"key":"2067_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-020-01371-7","author":"N Taha","year":"2020","unstructured":"Taha N, D\u2019Amato D, Hosein K, et al. Longitudinal functional changes with clinically significant radiographic progression in idiopathic pulmonary fibrosis: are we following the right parameters? Respir Res. 2020. https:\/\/doi.org\/10.1186\/s12931-020-01371-7.","journal-title":"Respir Res"},{"key":"2067_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17204-5","author":"P Bankhead","year":"2017","unstructured":"Bankhead P, Loughrey MB, Fern\u00e1ndez JA, et al. QuPath: open source software for digital pathology image analysis. Sci Rep. 2017. https:\/\/doi.org\/10.1038\/s41598-017-17204-5.","journal-title":"Sci Rep"},{"key":"2067_CR28","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41587-020-0472-9","volume":"38","author":"CR Merritt","year":"2020","unstructured":"Merritt CR, Ong GT, Church SE, et al. Multiplex digital spatial profiling of proteins and RNA in fixed tissue. Nat Biotechnol. 2020;38:586\u201399. https:\/\/doi.org\/10.1038\/s41587-020-0472-9.","journal-title":"Nat Biotechnol"},{"key":"2067_CR29","doi-asserted-by":"publisher","unstructured":"Beechem JM. High-Plex Spatially resolved RNA and protein detection using digital spatial profiling: a technology designed for immuno-oncology biomarker discovery and translational research. In: Methods in Molecular Biology. Humana Press Inc. 2020;563\u2013583. doi:https:\/\/doi.org\/10.1007\/978-1-4939-9773-2_25","DOI":"10.1007\/978-1-4939-9773-2_25"},{"key":"2067_CR30","doi-asserted-by":"crossref","unstructured":"Ashburner M, Ball CA, Blake JA, et al. Consortium GO. Gene Ontology: Tool for the unification of biology. Nat Genet. 2000;25:25\u201329.","DOI":"10.1038\/75556"},{"key":"2067_CR31","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S2213-2600(19)30342-X","volume":"8","author":"LK Troy","year":"2020","unstructured":"Troy LK, Grainge C, Corte TJ, et al. Diagnostic accuracy of transbronchial lung cryobiopsy for interstitial lung disease diagnosis (COLDICE): a prospective, comparative study. Lancet Respir Med. 2020;8:171\u201381. https:\/\/doi.org\/10.1016\/S2213-2600(19)30342-X.","journal-title":"Lancet Respir Med"},{"key":"2067_CR32","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1164\/rccm.200504-644OC","volume":"173","author":"M Selman","year":"2006","unstructured":"Selman M, Pardo A, Barrera L, et al. Gene expression profiles distinguish idiopathic pulmonary fibrosis from hypersensitivity pneumonitis. Am J Respir Crit Care Med. 2006;173:188\u201398. https:\/\/doi.org\/10.1164\/rccm.200504-644OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"2067_CR33","doi-asserted-by":"publisher","first-page":"0891","DOI":"10.1371\/journal.pmed.0020251","volume":"2","author":"A Pardo","year":"2005","unstructured":"Pardo A, Gibson K, Cisneros J, et al. Up-regulation and profibrotic role of osteopontin in human idiopathic pulmonary fibrosis. PLoS Med. 2005;2:0891\u2013903. https:\/\/doi.org\/10.1371\/journal.pmed.0020251.","journal-title":"PLoS Med"},{"key":"2067_CR34","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1164\/rccm.200510-1648OC","volume":"174","author":"MM Kelly","year":"2006","unstructured":"Kelly MM, Leigh R, Gilpin SE, et al. Cell-specific gene expression in patients with usual interstitial pneumonia. Am J Respir Crit Care Med. 2006;174:557\u201365. https:\/\/doi.org\/10.1164\/rccm.200510-1648OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"2067_CR35","doi-asserted-by":"publisher","first-page":"L1164","DOI":"10.1152\/ajplung.00220.2017","volume":"313","author":"D Alvarez","year":"2017","unstructured":"Alvarez D, Cardenes N, Sellares J, et al. IPF lung fibroblasts have a senescent phenotype. AmJ Physiol Lung Cell Mol Physiol. 2017;313:L1164-1173.","journal-title":"AmJ Physiol Lung Cell Mol Physiol"},{"key":"2067_CR36","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.ebiom.2018.12.052","volume":"40","author":"JJ Justice","year":"2019","unstructured":"Justice JJ, Nambiar AM, Tchkonia T, et al. Senolytics in idiopathic pulmonary fibrosis: results from a first-in-human, open-label, pilot study. EBioMedicine. 2019;40:554\u201363.","journal-title":"EBioMedicine"},{"key":"2067_CR37","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/B978-0-12-394311-8.00014-5","volume":"116","author":"A Gheldolf","year":"2013","unstructured":"Gheldolf A, Berx G. Cadherins and epithelial-to-mesenchymal transition. Prog Mol Biol Transl Sci. 2013;116:317\u201336.","journal-title":"Prog Mol Biol Transl Sci"},{"key":"2067_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cellimm.2018.01.002","volume":"325","author":"IG Luzina","year":"2018","unstructured":"Luzina IG, Salcedo MV, Rojas-Pena ML, et al. Transcriptomic evidence of immune activation in macroscopically normal-appearing and scarred lung tissues in idiopathic pulmonary fibrosis. Cell Immunol. 2018;325:1\u201313.","journal-title":"Cell Immunol"},{"key":"2067_CR39","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1097\/PAS.0000000000001725","volume":"45","author":"MJ Cecchini","year":"2021","unstructured":"Cecchini MJ, Tarmey T, Ferreira A, et al. Pathology, radiology, and genetics of interstitial lung disease in patients with shortened telomeres. Am J Surg Pathol. 2021;45:871\u201384. https:\/\/doi.org\/10.1097\/PAS.0000000000001725.","journal-title":"Am J Surg Pathol"},{"key":"2067_CR40","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.4161\/cc.9.12.11988","volume":"9","author":"Z Lu","year":"2010","unstructured":"Lu Z, Hunter T. Ubiquitylation and proteasomal degradation of the p21(Cip1), p27(Kip1) and p57(Kip2) CDK inhibitors. Cell Cycle. 2010;9:2342\u201352.","journal-title":"Cell Cycle"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-022-02067-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-022-02067-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-022-02067-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T16:14:04Z","timestamp":1654618444000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-022-02067-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,7]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2067"],"URL":"https:\/\/doi.org\/10.1186\/s12931-022-02067-w","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,7]]},"assertion":[{"value":"21 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research study was approved by the Western University Research Ethics Board (protocol n.113528) and Western University Clinical Research Impact Committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors of this abstract have indicated that they have no conflicts of interest that relate to the content of this publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"147"}}